ÀÏÀÚ Á¦¸ñ Ãâó
7/14 20:13 ¢ßÀ̳ëºôµå·¦, ¿ï»ê Áß±¸ ¡®Ã»³âµðµõÅÍ¡¯ »õ ¿î¿µ»ç¿¡ ¼±Á¤ Çѱ¹°æÁ¦
7/14 20:10 [´Üµ¶]¡®´Ú°ø¡¯ ¼­¿ï½Ã¡¦¸ð¾ÆÅ¸¿î ¹®ÅÎ ³·Ãá´Ù ¸ÅÀϰæÁ¦
7/14 20:09 "Çѱ¹¼­ 1Á¶7000¾ï ±Ü¾ú´Ù"¡¦¿Ü±¹ÀÎ ¹«¼·°Ô ¾µ¾î´ãÀº "À̰÷" Çѱ¹°æÁ¦
7/14 20:02 Ư°Ë, ±è°ÇÈñ ´ë¹ý ¼±°í ¿¬±â ½Åû¡¦"ÃÖ¼Ò ÇÑ´Þ ¹Ì·ï´Þ¶ó" Çѱ¹°æÁ¦
7/14 20:00 [ÁÖ½Ä]SKÇÏ´Ð ±¦È÷ ÆÈ¾Ò³ª¡¦¿ª´ë±Þ ÆÐ´Ð¼¿ µÚ ³ª¿Â "¶æ¹ÛÀÇ Àü¸Á" [ºÐ.. Çѱ¹°æÁ¦
7/14 20:00 »þ³ÚÀÎ ÁÙ ¾Ë¾Ò³×¡¦¹æÄÛ 1020åü »çÀ̼­ ÅÍÁø Çѱ¹ ºê·£µå Çѱ¹°æÁ¦
7/14 20:00 ÄÚÆ®¶ó, °æ±â ºÏºÎ AI Ȱ¿ë ¼öÃ⸶ÄÉÆÃ ¼³¸íȸ °³ÃÖ À̵¥Àϸ®
7/14 19:54 Ã౸Çùȸ, Çö´ë°¡ ´õºñ ÁÖ½É-¼±¼ö Ãæµ¹ »óȲ ÆÇÁ¤ ³í¶õ¿¡ "Á¤½É" ¿¬ÇÕ´º½º
7/14 19:53 South Korea Eases Biosimilar Approval Requirements, Allowing Waiv.. ÇコÄÚ¸®¾Æ
7/14 19:51 ³úÁ¾¾ç ¾Î´Â 3¼¼¾ÆÀÌ ¾ó±¼¿¡ µû±Í ÀÚ±¹ÀÌ¡¦25Â÷·Ê ÇдëÇÑ ¾î¸°ÀÌÁý±³»ç.. ¸ÅÀϰæÁ¦
7/14 19:51 ÀÌ ´ëÅë·É, ¿µ±¹ ¾Ø °øÁÖ Á¢°ß¡¦¡°ÇÑ¡¤¿µ ÇØ¾ç Çù·Â ´õ È®´ëµÇ±æ¡± ¸ÅÀϰæÁ¦
7/14 19:48 [ÁÖ½Ä]¡°´ë¸¶ºÒ»ç¶ó´õ´Ï ÀâÁÖó·³ ¿òÁ÷¿©¡±¡¦200¸¸¿øÂ¥¸® ÁÖ½Ä 43%Æø¶ô.. ¸ÅÀϰæÁ¦
7/14 19:48 [¼Óº¸] 1¸¸820¿ø vs 1¸¸620¿ø¡¦ÃÖÀúÀÓ±Ý 11Â÷ ¼öÁ¤¾È Çѱ¹°æÁ¦
7/14 19:48 [¼Óº¸] ³ë 1¸¸820¿ø¡¤»ç 1¸¸620¿ø¡¦ÃÖÀúÀÓ±Ý 11Â÷ ¼öÁ¤¾È ¸ÅÀϰæÁ¦
7/14 19:48 [¼Óº¸] ÃÖÀúÀÓ±Ý 1¸¸820¿ø vs 1¸¸620¿ø¡¦ÃÖÁ¾ °áÁ¤ ÀÓ¹Ú Çѱ¹°æÁ¦
Àüü : 2232  Ã³À½     ÀÌÀü    [6] [7] [8] [9] [10]    ´ÙÀ½    ³¡À¸·Î 

Ȩ > ¸®¼­Ä¡Á¤º¸ > °æÁ¦Á¾ÇÕ´º½º